Pharmacogenetics and pharmacogenomics: the silver bullet?
Hansen, K.
South Dakota Medicine the Journal of the South Dakota State Medical Association 61(5): 169; 171
2008
ISSN/ISBN: 0038-3317 PMID: 18630027 Document Number: 615078
Document emailed within 1 workday
Related Documents
Williams, B. 2004: Manny Martins: no "silver bullet" solution for TennCare Tennessee Medicine: Journal of the Tennessee Medical Association 97(3): 107-109O'Dowd, A. 2013: Standard tobacco packaging still being considered but is not a "silver bullet," says health department Bmj 347: F6751
Choh, J.H.; Adler, R.H. 1981: Penetrating bullet wound of chest with bronchoscopic removal of bullet Journal of Thoracic and Cardiovascular Surgery 82(1): 150-153
Maitre, S.; Jaber, K.; Perrot, J.L.; Guy, C.; Cambazard, F. 2002: Increased serum and urinary levels of silver during treatment with topical silver sulfadiazine Annales de Dermatologie et de Venereologie 129(2): 217-219
Chuangsuwanich, A.; Charnsanti, O.; Lohsiriwat, V.; Kangwanpoom, C.; Thong-In, N. 2011: The efficacy of silver mesh dressing compared with silver sulfadiazine cream for the treatment of pressure ulcers Journal of the Medical Association of Thailand 94(5): 559-565
Fredriksson, C.; Kratz, G.; Huss, F. 2009: Accumulation of Silver and Delayed Re-epithelialization in Normal Human Skin: An ex-vivo Study of Different Silver Dressings Wounds: a Compendium of Clinical Research and Practice 21(5): 116-123
Gusev, E.A.; Luk'ianenko, E.A.; Chelnokov, V.B. 1993: Low-silver and silver-free x-ray materials for medical diagnosis Meditsinskaia Tekhnika 2: 33-37
Nabiev, I.R.; Efremov, R.G.; Chumanov, G.D. 1986: Surface-enhanced Raman spectroscopy of biopolymers: membrane proteins, bacteriorhodopsin and rhodopsin adsorbed on silver electrodes and silver hydrosols Biofizika 31(4): 724-734
Pahl, A.; Benediktus, E.; Chialda, L. 2006: Pharmacogenomics of asthma Current Pharmaceutical Design 12(25): 3195-3206
Bapat, S.A.; Mishra, G.C. 2004: Stem cell pharmacogenomics Current Topics in Medicinal Chemistry 4(13): 1371-1383
Müller, M. 2003: Pharmacogenomics and drug response International Journal of Clinical Pharmacology and Therapeutics 41(6): 231-240
Puri, A.; Saif, M.Wasif. 2014: Pharmacogenomics update in pancreatic cancer Jop: Journal of the Pancreas 15(2): 114-117
Dubey, A.K.; Palaian, P.S.; Shankar, P.R. 2006: Pharmacogenomics--a new approach towards personalized medicine JPMA. Journal of the Pakistan Medical Association 56(9): 426
Ratnayake, W.M.Nimal. 2004: Overview of methods for the determination of trans fatty acids by gas chromatography, silver-ion thin-layer chromatography, silver-ion liquid chromatography, and gas chromatography/mass spectrometry Journal - Association of Official Analytical Chemists 87(2): 523-539
Read, C.Y. 2002: Pharmacogenomics: an evolving paradigm for drug therapy Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 11(3): 122-124
Grant, D.M. 1999: Pharmacogenomics and the changing face of clinical pharmacology Canadian Journal of Clinical Pharmacology 6(3): 131-132
Jörgensen, G. 1979: What is pharmacogenetics? Therapie der Gegenwart 118(5): 699
Lamy, M. 1972: Pharmacogenetics La Nouvelle Presse Medicale 1(46): 3103-3106
Traynor, K. 2020: Family medicine clinic finds success with pharmacogenomics American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 77(12): 914
Pang, T. 2003: Impact of pharmacogenomics on neglected diseases of the developing world American Journal of Pharmacogenomics: Genomics-Related Research in Drug Development and Clinical Practice 3(6): 393-398